Mycophenolate mofetil monotherapy in liver transplantation

Lancet (London, England)
|September 18, 2001
PubMed
Summary

Mycophenolate mofetil monotherapy improved renal failure in liver transplant patients but led to organ rejection. The trial was halted due to high rates of rejection, indicating risks associated with this immunosuppressive strategy.